Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00025012 · ClinicalTrials.gov registry record · NA
Isotretinoin in Preventing Skin Cancer
A NA study, sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS).
- Completed
- Registry status
- NA
- Development phase
NCT00025012 is a NA study that has completed, run by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS).
The verdict
NCT00025012, a NA study, has completed, sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS).
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. Isotretinoin may be effective in preventing the development or recurrence of skin cancer. PURPOSE: Clinical trial to study the effectiveness of isotretinoin in preventing or slowing the growth of skin cancer in patients who have xeroderma pigmentosum or basal cell carcinoma.
Interventions
- DRUG isotretinoin
Trial Details
| Field | Value |
|---|---|
| Start Date | 1991-06 |
| Est. Completion | 2004-02 |
| Phase | NA |
Sponsor
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)93 total trials
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00025012
The ClinicalTrials.gov registry entry for NCT00025012 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), which has 93 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which isotretinoin is the first listed.
NCT00025012 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00025012 about?
NCT00025012 is a clinical study titled "Isotretinoin in Preventing Skin Cancer". RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. Isotretinoin may be effective in preventing the development or recurrence of skin cancer. PURPOSE: Clinical trial to study the effectiveness of isotretinoin in preventing or slo...
What is the current status of trial NCT00025012?
This trial is currently completed. It is a NA study. The study started on 1991-06. Estimated completion is 2004-02.
What interventions are being tested in trial NCT00025012?
The interventions under investigation include: isotretinoin (DRUG).
Who is sponsoring clinical trial NCT00025012?
This trial is sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), which has 93 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.